Literature DB >> 9535434

Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation.

P Monagle, A Cochrane, B McCrindle, L Benson, W Williams, M Andrew.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535434     DOI: 10.1016/s0022-5223(98)70310-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  35 in total

1.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  The adult with a Fontan operation.

Authors:  Jamil Aboulhosn; John S Child
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

Review 4.  Long-term results of the Fontan operation.

Authors:  D J Driscoll
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

5.  Thrombotic events in critically ill children with myocarditis.

Authors:  Kimberly Y Lin; Basavaraj Kerur; Char M Witmer; Lauren A Beslow; Daniel J Licht; Rebecca N Ichord; Beth D Kaufman
Journal:  Cardiol Young       Date:  2013-09-09       Impact factor: 1.093

6.  Clinical research priorities in adult congenital heart disease.

Authors:  Timothy Cotts; Paul Khairy; Alexander R Opotowsky; Anitha S John; Anne Marie Valente; Ali N Zaidi; Stephen C Cook; Jamil Aboulhosn; Jennifer Grando Ting; Michelle Gurvitz; Michael J Landzberg; Amy Verstappen; Joseph Kay; Michael Earing; Wayne Franklin; Brian Kogon; Craig S Broberg
Journal:  Int J Cardiol       Date:  2013-12-24       Impact factor: 4.164

7.  Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure.

Authors:  Brian W McCrindle; Victor Zak; Lynn A Sleeper; Stephen M Paridon; Steven D Colan; Tal Geva; Lynn Mahony; Jennifer S Li; Roger E Breitbart; Renee Margossian; Richard V Williams; Welton M Gersony; Andrew M Atz
Journal:  Circulation       Date:  2009-12-21       Impact factor: 29.690

Review 8.  Thromboembolism and the role of anticoagulation in the Fontan patient.

Authors:  M L Jacobs; K K Pourmoghadam
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

9.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

10.  Thromboelastography of patients after fontan compared with healthy children.

Authors:  Leslie Raffini; Alexander Schwed; X Long Zheng; Maria Tanzer; Susan Nicolson; J William Gaynor; David Jobes
Journal:  Pediatr Cardiol       Date:  2009-04-09       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.